Ensayos clínicos

8.676 ensayos encontrados

CompletadoFase 3ClinicalTrials.gov

ABS-LT: A Phase 3, Long-Term, Open Label, Multicenter Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension

INTERVENTIONALInicio: 17 de nov de 2008ID: NCT00777920

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Lefamulin (BC 3781) Versus Moxifloxacin (With or Without Adjunctive Linezolid) in Adults With Community-Acquired Bacterial Pneumonia

INTERVENTIONALInicio: 1 de sept de 2015ID: NCT02559310

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH

INTERVENTIONALInicio: 30 de ago de 2018ID: NCT03626688

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH

INTERVENTIONALInicio: 25 de ene de 2021ID: NCT04576988

Activo, no reclutaFase 4ClinicalTrials.gov

A Phase 4, 52-week (Primary Analysis at 24-weeks), Randomized, Stratified, Open-label, Active-controlled, Parallel-group, Effectiveness Study, Comparing FF/UMEC/VI With Non-ellipta Usual Care (ICS/LABA) in Adult Participants With Uncontrolled Asthma

INTERVENTIONALInicio: 16 de abr de 2024ID: NCT06372496

TerminadoFase 2ClinicalTrials.gov

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of EDP-938 in Hematopoietic Cell Transplant Recipients With Acute Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

INTERVENTIONALInicio: 7 de jul de 2021ID: NCT04633187

CompletadoFase 3ClinicalTrials.gov

A Multi-centre, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects Who Participated in theMEA115588 or MEA115575 Trials

INTERVENTIONALInicio: 27 de may de 2013ID: NCT01842607

TerminadoFase 3ClinicalTrials.gov

ARTEMIS-IPF: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group, Event Driven Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects With Early Idiopathic Pulmonary Fibrosis (IPF)

INTERVENTIONALInicio: 1 de dic de 2008ID: NCT00768300

TerminadoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma

INTERVENTIONALInicio: 30 de ene de 2023ID: NCT05763121

DesconocidoClinicalTrials.gov

Multicentre, Open Label, Extension Study of Treatment With Gefitinib(IRESSA™) for Patients Completing Other Gefitinib Clinical Studies Who May Benefit From Gefitinib Treatment

EXPANDED_ACCESSID: NCT00683306

CompletadoClinicalTrials.gov

Lung Injury (Pulmonary Edema) in COVID-19: Treatment With Furosemide and Negative Fluid Balance (NEGBAL): a Case-Control Study

OBSERVATIONALInicio: 28 de nov de 2021ID: NCT05304702

CompletadoFase 3ClinicalTrials.gov

Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310

INTERVENTIONALInicio: 11 de sept de 2013ID: NCT01560637

CompletadoFase 2ClinicalTrials.gov

A Two-Part Study With a Birth Cohort (Observational Stage) for Early Diagnosis of Respiratory Syncytial Virus (RSV), Followed by an Optional Phase 2a, Randomized, Double-blind, Placebo-controlled Study (Interventional Stage) to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 in Infants With Acute Respiratory Tract Infection Due to RSV

INTERVENTIONALInicio: 10 de oct de 2019ID: NCT04068792

CompletadoClinicalTrials.gov

COVID-19 Sequelae: Treatment and Monitoring of Persistent Symptoms, a Decentralized Approach Focus on the Patient. Use of Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A.

INTERVENTIONALInicio: 22 de sept de 2021ID: NCT05531019

ReclutandoFase 2ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Participants With PPF

INTERVENTIONALInicio: 3 de abr de 2024ID: NCT06329401

Activo, no reclutaFase 3ClinicalTrials.gov

A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations

INTERVENTIONALInicio: 12 de oct de 2022ID: NCT05502237

CompletadoFase 4ClinicalTrials.gov

A 48 Week Extension to CTBM100C2401, a Single Arm, Open-label, Multicenter, Phase IV Extension Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis Who Completed Participation in CTBM100C2401.

INTERVENTIONALInicio: 1 de feb de 2013ID: NCT01775137

CompletadoFase 3ClinicalTrials.gov

Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)

INTERVENTIONALInicio: 2 de may de 2020ID: NCT04362137

Activo, no reclutaFase 3ClinicalTrials.gov

A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients With Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/R) to Janus Kinase (JAK) Inhibitor

INTERVENTIONALInicio: 12 de abr de 2021ID: NCT04576156

CompletadoFase 3ClinicalTrials.gov

Long-term Single-arm Open-label Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

INTERVENTIONALInicio: 17 de oct de 2008ID: NCT00667823